QT
OCUL icon

Quantbot Technologies’s Ocular Therapeutix OCUL Stock Holding History

Quantbot Technologies’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$343K Sell
34,966
-37,431
-52% -$339K 0.01% 1072
2026
Q1 		$613K Buy
+72,397
New +$690K 0.03% 788
2024
Q3 		– Sell
-10,834
Closed -$74.1K – 1720
2024
Q2 		$74.1K Sell
10,834
-35,666
-77% -$220K ﹤0.01% 1183
2024
Q1 		$423K Buy
+46,500
New +$330K 0.02% 796
2023
Q2 		– Sell
-3,254
Closed -$17.1K – 1845
2023
Q1 		$17.1K Buy
+3,254
New +$15.5K ﹤0.01% 1363
2022
Q2 		– Sell
-127
Closed – – 1997
2022
Q1 		$0 Sell
127
-14,981
-99% -$83K ﹤0.01% 1939
2021
Q4 		$105K Buy
+15,108
New +$117K 0.01% 861
2021
Q3 		– Sell
-3,151
Closed -$44K – 1783
2021
Q2 		$44K Buy
3,151
+1,951
+163% +$29.7K ﹤0.01% 1092
2021
Q1 		$19K Sell
1,200
-1,254
-51% -$24.2K ﹤0.01% 1177
2020
Q4 		$50K Sell
2,454
-1,828
-43% -$27.1K 0.01% 854
2020
Q3 		$32K Sell
4,282
-870
-17% -$7.22K ﹤0.01% 933
2020
Q2 		$42K Buy
+5,152
New +$34.1K 0.01% 740
2018
Q1 		– Sell
-1,328
Closed -$5K – 1425
2017
Q4 		$5K Sell
1,328
-600
-31% -$3.06K ﹤0.01% 1129
2017
Q3 		$11K Buy
1,928
+231
+14% +$1.49K ﹤0.01% 1086
2017
Q2 		$15K Sell
1,697
-1,075
-39% -$10.4K ﹤0.01% 1016
2017
Q1 		$25K Sell
2,772
-189
-6% -$1.57K ﹤0.01% 986
2016
Q4 		$24K Buy
+2,961
New +$23K ﹤0.01% 913

Other funds holding OCUL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $161M AUM 27.24% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Quantbot Technologies's OCUL Position: Q2 2026 in Review

Quantbot Technologies reduced its Ocular Therapeutix (OCUL) stake by 52% in Q2 2026, selling an estimated $339K and leaving 34,966 shares worth $343K. The position accounts for 0.01% of the portfolio, ranked #1072.

Quantbot Technologies first reported a position in OCUL in Q4 2016 and has held it in 17 quarters since. The position peaked at $613K in Q1 2026. 262 funds tracked by Wall St. Rank hold OCUL as of Q2 2026.

  • Quantbot Technologies held 34,966 shares of Ocular Therapeutix worth $343K as of Q2 2026.
  • Quantbot Technologies sold 37,431 Ocular Therapeutix shares in Q2 2026, an estimated $339K.
  • Ocular Therapeutix made up 0.01% of Quantbot Technologies's portfolio in Q2 2026, its #1072 holding.
  • Quantbot Technologies first reported a position in Ocular Therapeutix in Q4 2016 and has held it in 17 quarters since.
  • Quantbot Technologies's Ocular Therapeutix position peaked at $613K in Q1 2026.
  • 262 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q2 2026.

Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.